PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE

(19)

(11)

EP 1 337 525 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.10.2011 Bulletin 2011/40

(45)	Mention of the grant of the patent:
	01.06.2011 Bulletin 2011/22

(21)	Application number: 01998545.6

(22)	Date of filing: 30.11.2001

(51)

International Patent Classification (IPC):

C07D 401/12^(2006.01)
A61P 1/04^(2006.01)

A61K 31/44^(2006.01)

(86)	International application number:
	PCT/JP2001/010462

(87)	International publication number:
	WO 2002/044167 (06.06.2002 Gazette 2002/23)

(54)	PROCESS FOR THE CRYSTALLIZATION OF (R)- OR (S)-LANSOPRAZOLE VERFAHREN ZUR KRISTALLISATION VON (R)- ODER (S)-LANSOPRAZOL PROCEDE DE CRISTALLISATION DU (R)- OU DU (S)-LANSOPRAZOLE

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30)

Priority:

01.12.2000 JP 2000367757

(43)	Date of publication of application:
	27.08.2003 Bulletin 2003/35

(60)	Divisional application:
	10177469.3 / 2345650
	10184510.5

(73)	Proprietor: Takeda Pharmaceutical Company Limited
	Osaka 541-0045 (JP)

(72)	Inventors:
	HASHIMOTO, Hideo c/o Takeda Pharmaceutical Company Limited Oaza-Mitsui, Hikari-shi, Yamaguchi 743-8502 (JP) URAI, Tadashi Kawanishi-shi,Hyogo 666-0111 (JP)

(74)	Representative: Wright, Robert Gordon McRae
	Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR Sevenoaks Kent TN13 1XR (GB)

(56)

References cited: :

EP-A- 0 174 726
WO-A-96/02535

EP-A- 0 302 720
WO-A-97/02261

"Survey of Chemistry, Quaternary", KIGAN KAGAKU SOSETSU, no. 6, 1989, pages 32-33,
THE NEW SCIENTISTS, 1987, pages 5-9,
M. J. PIKAL ET AL.: "Thermal Decomposition of Amorphous .beta.-Lactam Antibacterials", J. PHARM. SCIENCES, vol. 66, no. 9, 9 September 1977 (1977-09-09), pages 1312-1316,
C. N. SUKENIK ET AL.: "Enhancement of a Chemical Reaction Rate by Proper Orientation of Reacting Molecules in the Solid State", J. AM. CHEM. SOC., vol. 97, no. 18, 3 September 1975 (1975-09-03), pages 5290-5291,
Maitland Jones, Jr.: "Organic Chemistry", page 1354,
A. G. MITCHELL: "Racemic Drugs: Racemic Mixture, Racemic Compound, or Pseudoracemate?", J. PHARM. PHARMACEUT. SCI., vol. 1, no. 1, 1998, pages 8-12,


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).